None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants will be recruited based on the presence of tinnitus-related symptoms. Individuals eligible for inclusion must have subjective tinnitus of at least 6 months duration, with stable symptoms for a minimum period of 3 months prior to enrollment. Based on hearing status, participants will be categorized into two groups: Group 1 will include individuals with subjective tinnitus and normal hearing sensitivity, and Group 2 will include individuals with subjective tinnitus associated with hearing loss.
Exclusion criteria
Exclusion criteria: Individuals will be excluded if they have objective or pulsatile tinnitus, conductive or mixed hearing loss, a history of neurological disorders, metallic implants or implanted electronic devices, active psychiatric illness or use of neuroactive medications, current or prior use of hearing aids or cochlear implants, pregnancy, or skin lesions at electrode placement sites.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study is expected to show a reduction in tinnitus severity following repeated tDCS, along with measurable changes in auditory processing. Improvements may be reflected as changes in latency and amplitude of ABR and P300 responses. A correlation between subjective tinnitus improvement and electrophysiological changes may provide objective support for the effectiveness of neuromodulation in tinnitus management.Timepoint: pre and post 10 sessions of tDCS | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvements may be reflected as changes in latency and amplitude of ABR and P300 responses. A correlation between subjective tinnitus improvement and electrophysiological changes may provide objective support for the effectiveness of neuromodulation in tinnitus management.Timepoint: Pre and post 10 sessions of tDCS for each participant | — |
Countries
India
Contacts
SNMC, Bagalkote